Clinical trials
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Fondazione Italiana Sclerosi Multipla | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hoffmann-La Roche | 1 |
| UCB Biopharma SRL | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 5 |
| Multiple Sclerosis | 3 |
| Demyelinating Diseases | 2 |
| Neuromyelitis Optica | 2 |
| Autoimmune Diseases | 1 |
| Optic Neuritis | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.